ZYDG-2

N/A

Report date: 2025/01/26 16:06:03
NME

Base Information

Drug NameZYDG-2
Drug Alias NameGPR40 agonist (Zydus Cadila Healthcare)ZYDG-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 1 agonists
TargetsFree fatty acid receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZydus Lifesciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZydus Lifesciences Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A